US · Healthcare

Xeris Pharmaceuticals Inc (XERS)

Biotechnology

Xeris Pharmaceuticals Inc (XERS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for XERS

P/E ratio

25.00

Xeris Pharmaceuticals Inc (XERS) — FAQ

What is XERS's P/E ratio?

The price-to-earnings (P/E) ratio for Xeris Pharmaceuticals Inc (XERS) is 25.00 (data as of 2026-05-24).

Does Xeris Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Xeris Pharmaceuticals Inc (XERS). Check the MyAverix Finance app for the latest dividend data.

What sector is Xeris Pharmaceuticals Inc in?

Xeris Pharmaceuticals Inc (XERS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is XERS listed on?

XERS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)